EIR Sciences is a contract research company providing services related to immunogenicity assessment and optimization of protein based medicines and biopharmaceuticals in order to save resources by reducing drug failure risk and speed up the process towards late stage pipeline products.
Our vision & mission:
EIR Sciences aspire to be the preferred partner within immunogenicity assessment.
EIR Sciences is dedicated to reduce risk of failure and aid faster decision making in biopharmaceutical drug development.
Our promise:
Transparency – we are committed to provide our clients with transparency of the methods and technology we use and the services we provide.
Cooperation – we go the extra mile to fulfill the specific needs of our clients.
World-class technologies – our technologies are based on award-winning and state-of-the-art methods, which are constantly improved and assessed by the global scientific community.
Strong scientific foundation – the EIR sciences team comprise some of the worlds leading experts in immunologic bioinformatics and immune assays